SCHEMBL14964176

SCHEMBL14964176

Nc1nc2ccc(-c3cc(F)cc(Cl)c3)cc2[nH]1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 1/20 0.58
HTR3B O95264 1/20 0.58
HTR3A P46098 1/20 0.58
BACE1 P56817 1/20 0.58
HTR3D Q70Z44 1/20 0.58
HTR3C Q8WXA8 1/20 0.58
MAP4K4 O95819 1/20 0.52
PIK3CA P42336 1/20 0.48
MTOR P42345 1/20 0.48
MAPK14 Q16539 1/20 0.47
PLAU P00749 1/20 0.46
ALDH1A1 P00352 4/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
KDM4E B2RXH2 2/20 0.43
MAPT P10636 2/20 0.43
HPGD P15428 2/20 0.43
NFKB1 P19838 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
HSD17B10 Q99714 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3716080 0.89 MAP4K4 (0.49) HTR3EHTR3BHTR3ABACE1HTR3D
Bromide SCHEMBL2380345 0.87 MAP4K4 (0.48) HTR3EHTR3BHTR3ABACE1HTR3D
Bromide SCHEMBL118833 0.87 MAP4K4 (0.48) HTR3EHTR3BHTR3ABACE1HTR3D
SCHEMBL14964175 0.80 CHEK2 (0.45) MAP4K4MEN1KMT2APGRTHRB
SCHEMBL11713250 0.75 HTR3E (0.58) HTR3EHTR3BHTR3ABACE1HTR3D
SCHEMBL31651401 0.74 PLAU (0.61) HTR3EHTR3BHTR3ABACE1HTR3D
SCHEMBL1887281 0.74 PLAU (0.61) HTR3EHTR3BHTR3ABACE1HTR3D
SCHEMBL658809 0.74 HTR3E (1.00) HTR3EHTR3BHTR3ABACE1HTR3D
SCHEMBL11712219 0.73 ALDH1A1 (0.58) HTR3EHTR3BHTR3ABACE1HTR3D
SCHEMBL3866103 0.72 HTR3E (0.55) HTR3EHTR3BHTR3ABACE1HTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8450354-B2 Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as β-secretase inhibitors HIGH POINT PHARMACEUTICALS, LLC (US) 2013-05-28 US claimed